Solid Biosciences Inc.
SLDB
$3.29
-$0.015-0.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -109.47% | -55.98% | -1.80% | 19.18% | -34.22% |
| Total Depreciation and Amortization | 129.11% | -31.12% | 11.97% | -51.70% | -60.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 470.68% | 353.02% | -16.14% | -57.58% | 110.70% |
| Change in Net Operating Assets | 184.79% | 132.46% | 101.17% | -142.32% | 14.68% |
| Cash from Operations | -42.37% | -32.47% | 21.84% | 10.01% | 39.61% |
| Capital Expenditure | -126.67% | 96.08% | 46.64% | 70.55% | 89.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.59% | 54.76% | 89.75% | -201.52% | 28.09% |
| Cash from Investing | -14.86% | 55.40% | 89.27% | -203.30% | -31.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,299.60% | -- | 110.58% | -- | -99.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,274.26% | -- | 91.06% | -- | -99.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.50% | 26.08% | 70.38% | 370.15% | -76.51% |